UBS ASSET MANAGEMENT AMERICAS LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$90,802,000
+103084.1%
62,1930.0%0.00%
Q4 2016$88,000
-58.1%
62,193
-48.2%
0.00%
Q3 2016$210,000
+2.4%
120,0930.0%0.00%
Q2 2016$205,000
-13.1%
120,0930.0%0.00%
Q1 2016$236,000
+0.4%
120,093
-3.0%
0.00%
Q4 2015$235,000
-0.4%
123,8110.0%0.00%
Q3 2015$236,000
-51.3%
123,811
+18.6%
0.00%
Q2 2015$485,000
+13.8%
104,411
+7.2%
0.00%
Q1 2015$426,000
+31.9%
97,411
+5.0%
0.00%
Q4 2014$323,000
-8.5%
92,811
+10.3%
0.00%
Q3 2014$353,000
-28.4%
84,1110.0%0.00%
Q2 2014$493,000
-7.0%
84,1110.0%0.00%
-100.0%
Q1 2014$530,000
+7.7%
84,1110.0%0.00%0.0%
Q4 2013$492,000
+14.2%
84,111
+2.8%
0.00%0.0%
Q3 2013$431,000
-31.5%
81,8110.0%0.00%0.0%
Q2 2013$629,00081,8110.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 1,952,891$2,852,0000.72%
Nine Chapters Capital Management LLC 180,200$263,0000.36%
Camber Capital Management LP 4,250,000$6,205,0000.25%
TFS CAPITAL LLC 340,092$497,0000.16%
ASCEND CAPITAL, LLC 1,008,949$1,473,0000.07%
Acrospire Investment Management LLC 39,781$58,0000.05%
OXFORD ASSET MANAGEMENT LLP 1,081,912$1,580,0000.04%
Jacobi Capital Management LLC 35,000$49,0000.02%
Renaissance Technologies 8,479,445$12,380,0000.02%
A.R.T. Advisors, LLC 238,036$347,0000.02%
View complete list of ARENA PHARMACEUTICALS INC shareholders